BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9667254)

  • 1. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors.
    Loprinzi CL; Pisansky TM; Fonseca R; Sloan JA; Zahasky KM; Quella SK; Novotny PJ; Rummans TA; Dumesic DA; Perez EA
    J Clin Oncol; 1998 Jul; 16(7):2377-81. PubMed ID: 9667254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer.
    Quella SK; Loprinzi CL; Sloan J; Novotny P; Perez EA; Burch PA; Antolak SJ; Pisansky TM
    J Urol; 1999 Jul; 162(1):98-102. PubMed ID: 10379749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors.
    Bordeleau L; Pritchard KI; Loprinzi CL; Ennis M; Jugovic O; Warr D; Haq R; Goodwin PJ
    J Clin Oncol; 2010 Dec; 28(35):5147-52. PubMed ID: 21060031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine.
    Loprinzi CL; Flynn PJ; Carpenter LA; Atherton P; Barton DL; Shanafelt TD; Rummans TA; Sloan JA; Adjei AA; Mincey BA; Fitch TR; Collins M
    J Palliat Med; 2005 Oct; 8(5):924-30. PubMed ID: 16238505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
    Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
    J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
    Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
    Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hot flashes in patients who have breast cancer with venlafaxine and clonidine: a randomized, double-blind, placebo-controlled trial.
    Boekhout AH; Vincent AD; Dalesio OB; van den Bosch J; Foekema-Töns JH; Adriaansz S; Sprangers S; Nuijen B; Beijnen JH; Schellens JH
    J Clin Oncol; 2011 Oct; 29(29):3862-8. PubMed ID: 21911720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine for hot flushes.
    Barlow DH
    Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
    [No Abstract]   [Full Text] [Related]  

  • 9. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
    Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
    Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
    Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
    Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial.
    Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; LaVasseur BI; Barton DL; Novotny PJ; Dakhil SR; Rodger K; Rummans TA; Christensen BJ
    Lancet; 2000 Dec; 356(9247):2059-63. PubMed ID: 11145492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
    Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
    Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonhormonal agents show promise against hot flashes.
    Gottlieb N
    J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
    [No Abstract]   [Full Text] [Related]  

  • 14. Venlafaxine hydrochloride for the treatment of hot flashes.
    Schober CE; Ansani NT
    Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    Irani J; Salomon L; Oba R; Bouchard P; Mottet N
    Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial to assess the impact of venlafaxine and soy protein on hot flashes and quality of life in men with prostate cancer.
    Vitolins MZ; Griffin L; Tomlinson WV; Vuky J; Adams PT; Moose D; Frizzell B; Lesser GJ; Naughton M; Radford JE; Shaw EG
    J Clin Oncol; 2013 Nov; 31(32):4092-8. PubMed ID: 24081940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
    Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
    JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and Comparison of Citalopram and Venlafaxine for Management of Hot Flashes in Women with Breast Cancer.
    Taleghani SY; Etesam F; Esfandbod M
    Drug Res (Stuttg); 2023 Oct; 73(8):465-472. PubMed ID: 37647930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot evaluation of paroxetine for treating hot flashes in men.
    Loprinzi CL; Barton DL; Carpenter LA; Sloan JA; Novotny PJ; Gettman MT; Christensen BJ
    Mayo Clin Proc; 2004 Oct; 79(10):1247-51. PubMed ID: 15473404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of postmenopausal hot flushes with venlafaxine hydrochloride: a randomized, controlled trial.
    Evans ML; Pritts E; Vittinghoff E; McClish K; Morgan KS; Jaffe RB
    Obstet Gynecol; 2005 Jan; 105(1):161-6. PubMed ID: 15625158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.